【4557】医学生物学研究所〔上場廃止〕

臨床検査薬・研究用試薬。親会社はJSR。

JQS

医薬品医薬

＞

その他医療・医薬品医他

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2021.03	2020/10/27	Q2予	9,700	↑	+3.7%	+3.7%	1,800	↑	+20.0%	+20.0%	1,800	↑	+16.1%	+16.1%	1,550	↑	+24.0%	+24.0%
2021.03	2020/07/28	Q1予	9,350	→	0.0%	0.0%	1,500	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,250	→	0.0%	0.0%
2021.03	2020/04/28	当初予	9,350	-	-	-	1,500	-	-	-	1,550	-	-	-	1,250	-	-	-
2020.03	2020/04/28	実	9,229	↓	-0.8%	+7.3%	1,334	↓	-4.7%	+33.4%	1,326	↑	+2.0%	+32.6%	1,266	↑	+5.5%	+48.9%
2020.03	2020/03/31	修正予	9,300	→	0.0%	+8.1%	1,400	→	0.0%	+40.0%	1,300	→	0.0%	+30.0%	1,200	↑	+9.1%	+41.2%
2020.03	2020/01/28	Q3予	9,300	→	0.0%	+8.1%	1,400	→	0.0%	+40.0%	1,300	→	0.0%	+30.0%	1,100	→	0.0%	+29.4%
2020.03	2019/10/29	修正予	9,300	↑	+8.1%	+8.1%	1,400	↑	+40.0%	+40.0%	1,300	↑	+30.0%	+30.0%	1,100	↑	+29.4%	+29.4%
2020.03	2019/07/30	Q1予	8,600	→	0.0%	0.0%	1,000	→	0.0%	0.0%	1,000	→	0.0%	0.0%	850	→	0.0%	0.0%
2020.03	2019/04/23	当初予	8,600	-	-	-	1,000	-	-	-	1,000	-	-	-	850	-	-	-
2019.03	2019/04/23	実	8,182	↑	+1.0%	+7.7%	488	↑	+22.0%	+112.2%	552	↑	+31.4%	+224.7%	316	↑	+97.5%	+110.7%
2019.03	2019/03/28	修正予	8,100	↑	+6.6%	+6.6%	400	↑	+73.9%	+73.9%	420	↑	+147.1%	+147.1%	160	↑	+362.3%	+6.7%
2019.03	2019/01/29	Q3予	7,600	→	0.0%	0.0%	230	→	0.0%	0.0%	170	→	0.0%	0.0%	-61	→	0.0%	-140.7%
2019.03	2018/11/16	修正予	7,600	→	0.0%	0.0%	230	→	0.0%	0.0%	170	→	0.0%	0.0%	-61	↓	-140.7%	-140.7%
2019.03	2018/10/30	Q2予	7,600	→	0.0%	0.0%	230	→	0.0%	0.0%	170	→	0.0%	0.0%	150	→	0.0%	0.0%
2019.03	2018/07/31	Q1予	7,600	→	0.0%	0.0%	230	-	-	-	170	→	0.0%	0.0%	150	→	0.0%	0.0%
2019.03	2018/04/24	当初予	7,600	-	-	-	-	-	-	-	170	-	-	-	150	-	-	-
2018.03	2018/04/24	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2018.03	2018/04/20	修正予	7,072	↓	-0.4%	-0.4%	-	-	-	-	11	↑	+155.0%	+106.5%	-59	↑	+41.0%	+68.8%
2018.03	2018/01/30	修正予	7,100	→	0.0%	0.0%	50	→	0.0%	0.0%	-20	↑	+88.2%	+88.2%	-100	↑	+47.1%	+47.1%
2018.03	2017/10/27	Q2予	7,100	→	0.0%	0.0%	50	→	0.0%	0.0%	-170	→	0.0%	0.0%	-189	→	0.0%	0.0%
2018.03	2017/07/25	Q1予	7,100	→	0.0%	0.0%	50	→	0.0%	0.0%	-170	→	0.0%	0.0%	-189	→	0.0%	0.0%
2018.03	2017/04/25	当初予	7,100	-	-	-	50	-	-	-	-170	-	-	-	-189	-	-	-
2017.03	2017/04/25	実	7,348	→	0.0%	-1.1%	85	→	0.0%	-	64	→	0.0%	+146.2%	188	→	0.0%	-36.7%
2017.03	2017/04/20	修正予	7,348	↓	-1.1%	-1.1%	85	↑	-	-	64	↑	+146.2%	+146.2%	188	↓	-36.7%	-36.7%
2017.03	2017/01/24	Q3予	7,430	→	0.0%	0.0%	0	→	-	-	26	→	0.0%	0.0%	297	→	0.0%	0.0%
2017.03	2016/10/28	Q2予	7,430	→	0.0%	0.0%	0	→	-	-	26	→	0.0%	0.0%	297	→	0.0%	0.0%
2017.03	2016/04/28	当初予	7,430	-	-	-	0	-	-	-	26	-	-	-	297	-	-	-
2016.03	2016/04/28	実	8,056	→	0.0%	-11.3%	-368	↓	-4.8%	-417.2%	-449	↓	-0.4%	-497.3%	-1,142	↑	+1.3%	-1412.6%
2016.03	2016/04/19	修正予	8,056	↓	-0.5%	-11.3%	-351	↓	-8.3%	-402.6%	-447	↓	-25.2%	-495.6%	-1,157	↑	+3.6%	-1429.9%
2016.03	2016/02/16	修正予	8,093	↓	-10.9%	-10.9%	-324	↓	-379.3%	-379.3%	-357	↓	-415.9%	-415.9%	-1,200	↓	-1479.3%	-1479.3%
2016.03	2016/01/26	Q3予	9,086	→	0.0%	0.0%	116	→	0.0%	0.0%	113	→	0.0%	0.0%	87	→	0.0%	0.0%
2016.03	2015/10/26	Q2予	9,086	→	0.0%	0.0%	116	→	0.0%	0.0%	113	→	0.0%	0.0%	87	→	0.0%	0.0%
2016.03	2015/07/27	Q1予	9,086	→	0.0%	0.0%	116	-	-	-	113	→	0.0%	0.0%	87	→	0.0%	0.0%
2016.03	2015/04/27	当初予	9,086	-	-	-	-	-	-	-	113	-	-	-	87	-	-	-
2015.03	2015/04/27	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2015.03	2015/01/26	Q3予	7,773	→	0.0%	-1.0%	-789	→	0.0%	-558.7%	-680	→	0.0%	-569.0%	-754	→	0.0%	-693.7%
2015.03	2015/01/09	修正予	7,773	↓	-1.0%	-1.0%	-789	↓	-558.7%	-558.7%	-680	↓	-569.0%	-569.0%	-754	↓	-693.7%	-693.7%
2015.03	2014/10/27	Q2予	7,854	→	0.0%	0.0%	172	→	0.0%	0.0%	145	→	0.0%	0.0%	127	→	0.0%	0.0%
2015.03	2014/07/29	Q1予	7,854	→	0.0%	0.0%	172	→	0.0%	0.0%	145	→	0.0%	0.0%	127	→	0.0%	0.0%
2015.03	2014/05/02	当初予	7,854	-	-	-	172	-	-	-	145	-	-	-	127	-	-	-
2014.03	2014/05/02	実	7,172	→	0.0%	-2.8%	-519	→	0.0%	-88.7%	-476	→	0.0%	-157.3%	-418	→	0.0%	-216.7%
2014.03	2014/04/21	修正予	7,172	↓	-2.8%	-2.8%	-519	↓	-88.7%	-88.7%	-476	↓	-157.3%	-157.3%	-418	↓	-216.7%	-216.7%
2014.03	2014/01/31	当初予	7,378	-	-	-	-275	-	-	-	-185	-	-	-	-132	-	-	-

【4557】医学生物学研究所 〔上場廃止〕 臨床検査薬・研究用試薬。親会社はJSR。

業績予想修正履歴

【4557】医学生物学研究所〔上場廃止〕

臨床検査薬・研究用試薬。親会社はJSR。